Real-world evidence with extrafine single-inhaler triple therapy in asthma: the TriMaximize study

被引：0
|
作者：
Gessner, C. [1 ]
Akyildiz, B. [2 ]
Cesarz, K. [3 ]
Sauer, A. [3 ]
Bogoevska, V [3 ]
Criee, P. C. [4 ]
机构：
[1] Praxis Pois Leipzig Gbr DE, Pois Leipzig Gbr Gessner & Gessner, Hamburg, Germany
[2] Chiesi GmbH, Hamburg, Germany
[3] Chiesi GmbH Hamburg, Hamburg, Germany
[4] Evangel Hosp Gottingen Weende, Em Dept Sleep & Resp Med, Gottingen, Germany
来源：
PNEUMOLOGIE | 2022年 / 76卷
关键词：
D O I：
10.1055/s-0042-1747699
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 58
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
    Trinkmann, F.
    Nachtigall, D.
    Bogoevska, V
    Akyildiz, B.
    Borucki, T.
    Grickschat, V
    Gessner, C.
    [J]. PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [2] First Real-World Evidence on High Dose Strength of Extrafine Single-Inhaler Triple Therapy in Asthma Patients after Three Months of Treatment TriMaximize Study
    Gessner, C.
    Bogoevska, V
    Nachtigall, D.
    Akyildiz, B.
    Martini, M.
    Wendt, A.
    Criee, C.
    [J]. PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [3] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
  • [4] TriOptimize X: Improved adherence by extrafine single-inhaler triple therapy in real-world
    Criee, C.
    Trinkmann, F.
    Gueldenring, S.
    Loeper, N.
    Bogoevska, V
    Gessner, C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Change in treatment adherence after three months of treatment with extrafine formulation single-inhaler triple therapy in patients with asthma: the TriMaximize study
    Trinkmann, Frederik
    Akyildiz, Berktan
    Ulrik, Charlotte Suppli
    Nachtigall, Detlef
    Pohl, Wolfgang
    Bogoevska, Valentina
    Russell, Richard
    Grickschat, Veronika
    Gessner, Christian
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Impact of extrafine formulation single-inhaler triple therapy on lung function after three months of treatment in patients with asthma: the TriMaximize study
    Gessner, Christian
    Akyildiz, Berktan
    Russell, Richard
    Nachtigall, Detlef
    Ulrik, Charlotte Suppli
    Bogoevska, Valentina
    Pohl, Wolfgang
    Licht, Bjoern
    Criee, Carl-Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Effect on asthma control in patients with asthma and concomitant COPD after three months of treatment with extrafine formulation single-inhaler triple therapy TriMaximize study
    Timmermann, Hartmut
    Akyildiz, Berktan
    Bogoevska, Valentina
    Russell, Richard
    Nachtigall, Detlef
    Pohl, Wolfgang
    Ulrik, Charlotte Suppli
    Wendt, Andreas
    Gessner, Christian
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
    Gessner, C.
    Akyildiz, B.
    Nachtigall, D.
    Nudo, E.
    Boeing, S.
    Timmermann, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    [J]. RESPIRATORY MEDICINE, 2021, 182
  • [10] TRICOP - A real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
12345